Rank product bets by pain evidence, confidence, and speed to proof.
Clustered pain signals roll into scored opportunities with source diversity, evidence counts, and validation plans kept visible at every rank.
3 clusters represented
Any cheaper alternative for customer health score dashboards? leads the radar
Quotes, snippets, or linked pain IDs
Distinct channels across ranked clusters
The radar separates market pull from proof burden so a high-pain cluster does not hide weak evidence or slow implementation.
Each cluster should carry trend, diversity, and member depth before it graduates into a product idea.
| Cluster | Trend | Sources | Signals |
|---|---|---|---|
customer-health-monitoring__alternative-request__operations-or-revenue-team operations or revenue team signals grouped by shared workflow and pain type. | 67 | 1 | 1 |
reporting-and-account-review__manual-workflow__operations-or-revenue-team operations or revenue team signals grouped by shared workflow and pain type. | 56 | 2 | 2 |
data-export-monitoring__failed-tool__operations-or-revenue-team operations or revenue team signals grouped by shared workflow and pain type. | 55 | 1 | 1 |
operations or revenue team appears to have alternative request pain around customer health monitoring.
Score 67/100, led by willingness to pay (88/100).
Any cheaper alternative for customer health score dashboards?
Pricing hypothesis pending evidence review.
operations or revenue team appears to have manual workflow pain around reporting and account review.
Score 63/100, led by pain intensity (72/100).
Export fails on large customer workspaces We have to manually stitch CSV chunks after every export.
Pricing hypothesis pending evidence review.
operations or revenue team appears to have failed tool pain around data export monitoring.
Score 55/100, led by urgency (74/100).
How do I monitor failed scheduled exports across client accounts?
Pricing hypothesis pending evidence review.
operations or revenue team appears to have manual workflow pain around reporting and account review.
Score 49/100, led by pain intensity (58/100).
Our ops team still copies numbers across three tools every Friday.
Pricing hypothesis pending evidence review.